Consolidated Statements of Cash Flows (USD $)	12 Months Ended		67 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Cash Flows from Operating Activities
Net Loss	$ (6,609,864)	$ (2,471,147)	$ (12,621,407)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	6,348	2,587	9,559
Amortization of debt issuance costs	28,229	58,458	126,742
Amortization of bond premium	50,781		50,781
Re-measurement of fair value of stock warrants liability	30,440	3,540	35,020
Non-cash consideration for rent			15,624
Stock based compensation	571,924	217,896	925,959
Increase (decrease) in cash arising from changes in assets and liabilities:
Related party receivable	(15,375)	(9,571)	(24,946)
Prepaid expenses and other current assets	(1,008,202)	(52,843)	(1,066,638)
Restricted cash	24,962	(24,502)	(1,252)
Deposits		200	(9,320)
Accounts payable	146,446	85,323	651,917
Accrued expenses and other payables	373,842	103,307	503,050
Accrued interest	11,601	13,077	76,635
Net Cash Used in Operating Activities	(6,388,868)	(2,073,675)	(11,328,276)
Cash Flows from Investing Activities
Purchases of short term investments	(17,347,946)		(17,347,946)
Purchase of property and equipment	(49,319)	(1,780)	(63,312)
Net Cash Used in Investing Activities	(17,397,265)	(1,780)	(17,411,258)
Cash Flows from Financing Activities
Proceeds from initial public offering, net of underwriting discounts	25,110,000		25,110,000
Related party payable		(12,500)
Borrowings on notes payable	200,000	950,000	1,150,000
Borrowings on line of credit			273,427
Payments on notes payable	(925,000)	(225,000)	(1,150,000)
Payments on line of credit			(273,427)
Issuance of convertible notes payable, net of issuance costs		197,099	2,781,636
Payments on convertible notes payable	(197,099)		(197,099)
Issuance of common stock	540	11,325	12,330
Exercise of stock options	54,042		54,042
Stock issuance costs	(944,478)	(22,419)	(992,062)
Net Cash Provided By Financing Activities	28,348,095	1,981,839	33,306,526
Net Increase in Cash and Cash Equivalents	4,561,962	(93,616)	4,566,992
Cash and Cash Equivalents - Beginning of Period	5,030	98,646
Cash and Cash Equivalents - End of Period	4,566,992	5,030	4,566,992
Supplemental Disclosure for Cash Flow Information
Interest paid	60,922	29,049	135,606
Supplemental Schedule of Noncash Investing and Financing Activities
Beneficial conversion charge	2,300,000		2,300,000
Issuance of preferred stock warrants and debt issuance costs		31,680	87,570
Cancellation of common stock			65
Non-cash consideration for rent			15,624
Non-cash conversion of preferred stock into common stock	386		386
Preferred stock dividend	361,668		361,668
Series A Preferred Stock [Member]
Cash Flows from Financing Activities
Issuance of preferred stock		1,083,334	1,487,589
Series B-1 Preferred Stock [Member]
Cash Flows from Financing Activities
Issuance of preferred stock	$ 5,050,090		$ 5,050,090